October 22, 2021 SARC Appoints Dr. Jonathan Fletcher To New Role of Chief Scientific Officer ANN ARBOR, MI October 22, 2021 – SARC (Sarcoma Alliance for Research Through Collaboration) is pleased to announce that Jonathan Fletcher, M.D., has been appointed Chief Scientific Officer (CSO), a … Read more
October 12, 2021 SARC 2022 Career Development Award SARC is pleased to announce our 2022 Career Development Award (CDA) funding opportunity. Past graduates (link here) of the SARC CDA program are pursuing productive independent careers at leading institutions … Read more
Epithelioid Sarcoma White Paper Published The Epithelioid Sarcoma Collaborative and SARC partner to help identify priority areas for new efforts to better inform patients, caregivers, and care providers. Read more
August 31, 2021 SARC024 Texas Children’s Cancer and Hematology Centers is now open to enrollment in SARC024 (Regorafenib/Refractory Liposarcoma, Osteogenic Sarcoma, Ewing/Ewing-like Sarcomas). SARC024 sites include: • Atrium Health Levine Cancer Institute (Atlanta, GA)• … Read more
July 30, 2021 SARC appoints Chief Scientific Officer SARC is pleased to announce that Dr. Jonathan Fletcher has been appointed Chief Scientific Officer. Dr. Fletcher is a lab-based medical and pediatric oncologist at Harvard Medical School, Brigham and Women’s … Read more
July 16, 2021 July is Sarcoma Awareness Month SARC collaborator SFA is hosting a virtual Advocacy Day on July 21, 2021, during Sarcoma Awareness Month. If you would like to be a part of this day, or to learn … Read more
June 22, 2021 JUNE 4, 2021 SARC SEMIANNUAL MEETING Thank you for attending the 2021 SARC Semiannual Virtual Meeting on June 4, 2021. If you were not able to join the virtual event please view the agenda along with … Read more
June 2, 2021 It’s not too late! REGISTER NOW: SARC Semiannual Meeting SARC Semiannual Virtual Meeting Friday, June 4, 20219:00 am–12:00 pm EDT Click REGISTER TODAY Registrants will receive a meeting link in advance of the virtual event. Read more
May 24, 2021 Understanding Adoptive Cell Therapy for Sarcoma Adoptive Cell Therapy is a type of cancer treatment that uses your own immune system to treat your cancer; it may be an option for patients with some types of … Read more
May 7, 2021 Message from SARC President & CEO “I’d like to share an abridged view into some of SARC’s present and future research initiatives and strategic planning to evolve SARC’s collaborative model for even greater impact…Among the areas … Read more